StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck non-GAAP Diluted Earnings per Share ($) ($)

Form 8-K Supplemental Table 2a (GAAP to Non-GAAP Reconciliation)

QuarterlyAnnual
Latest, Q2 2026
-0.13
Period ended Jun 30, 2026
Change on a year earlier
-106.1%
2.13 in Q2 2025
History
38 quarters
Since Q4 2016
Sources
32
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Diluted Earnings per Share ($) ($)Year on yearSource
Q2 2026Jun 30, 2026-0.13-106.1%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2026Mar 31, 2026-1.28-157.7%Form 8-K (tm2612241d1_ex99-1.htm, filed 2026-04-30) ↗
Q4 2025Dec 31, 20252.04+18.6%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2025Sep 30, 20252.58+64.3%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2025Jun 30, 20252.13-6.6%Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Q1 2025Mar 31, 20252.22+7.2%Form 8-K (tm2612241d1_ex99-1.htm, filed 2026-04-30) ↗
Q4 2024Dec 31, 20241.72+5,633.3%Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Q3 2024Sep 30, 20241.57-26.3%Form 8-K (tm2529620d1_ex99-1.htm, filed 2025-10-30) ↗
Q2 2024Jun 30, 20242.28-210.7%Form 8-K (tm2521736d1_ex99-1.htm, filed 2025-07-29) ↗
Q1 2024Mar 31, 20242.07+47.9%Form 8-K (tm2512885d1_ex99-1.htm, filed 2025-04-24) ↗
Q4 2023Dec 31, 20230.03-98.1%Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗
Q3 2023Sep 30, 20232.13+15.1%Form 8-K (tm2426878d1_ex99-1.htm, filed 2024-10-31) ↗
Q2 2023Jun 30, 2023-2.06-210.2%Form 8-K (tm2420272d1_ex99-1.htm, filed 2024-07-30) ↗
Q1 2023Mar 31, 20231.40-34.6%Form 8-K (tm2412490d1_ex99-1.htm, filed 2024-04-25) ↗
Q4 2022Dec 31, 20221.62–Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗
Q3 2022Sep 30, 20221.85+3.9%Form 8-K (tm2328962d1_ex99-1.htm, filed 2023-10-26) ↗

Breakdown

What makes up non-gaap diluted earnings per share ($)

Cite this data

StockData. (2026). Merck Non-GAAP Diluted Earnings per Share ($) ($), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/nongaap_eps

See every metric in the Merck KPI table. Data updated Oct 26, 2026.